264
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Telehealth access among hematology patients during the COVID-19 pandemic in Australia: a cross-sectional survey

ORCID Icon, , , , &
Pages 1488-1491 | Received 25 Oct 2021, Accepted 20 Dec 2021, Published online: 06 Jan 2022

References

  • Lee LY, Cazier J-B, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316.
  • Leach CR, Kirkland EG, Masters M, et al. Cancer survivor worries about treatment disruption and detrimental health outcomes due to the COVID-19 pandemic. J Psychosoc Oncol. 2021;39(3):347–365.
  • Miaskowski C, Paul SM, Snowberg K, et al. Loneliness and symptom burden in oncology patients during the COVID‐19 pandemic. Cancer. 2021;127(17):3246–3253.
  • Zomerdijk N, Jongenelis M, Yuen E, et al. Experiences and needs of people with haematological cancers during the COVID‐19 pandemic: a qualitative study. Psycho‐Oncol. 2021;2021:1–9.
  • Tzelepis F, Paul CL, Sanson-Fisher RW, et al. Unmet supportive care needs of haematological cancer survivors: rural versus urban residents. Ann Hematol. 2018;97(7):1283–1292.
  • Sansom‐Daly UM, Bradford N. Grappling with the “human” problem hiding behind the technology: telehealth during and beyond COVID-19. Psychooncology. 2020;29(9):1404–1408.
  • Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892.
  • Zomerdijk N, Jongenelis M, Short CE, et al. Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic. Support Care Cancer. 2021;29(12):1–10.
  • Australian Institute of Health and Welfare. Cancer data in Australia: Australian Government; 2021; [cited 24 November 2021]. Available from: https://www.aihw.gov.au/reports-data/health-conditions-disability-deaths/cancer/overview.
  • Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034.
  • Richards M, Anderson M, Carter P, et al. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1(6):565–567.
  • Cancer Australia. Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: Skin, breast and colorectal cancers, and telehealth service Surrey Hills, NSW: Cancer Australia; 2020; [cited 11 February 2021]. Available from: https://www.canceraustralia.gov.au/resources.
  • Flynn D, Moloney E, Bhattarai N, et al. COVID-19 pandemic in the United Kingdom. Health Policy Technol. 2020;9(4):673–691.
  • Burbury K, Wong ZW, Yip D, et al. Telehealth in cancer care: during and beyond the COVID-19 pandemic. Intern Med J. 2021;51(1):125–133.
  • Grassi L, Fujisawa D, Odyio P, et al. Disparities in psychosocial cancer care: a report from the international federation of Psycho-oncology Societies. Psychooncology. 2016;25(10):1127–1136.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.